Chargement en cours...
Knockdown of NF-κB1 by shRNA Inhibits the Growth of Renal Cell Carcinoma In Vitro and In Vivo
Renal cell carcinoma (RCC) accounts for approximately 2%–3% of human malignancies and is the most aggressive among urologic tumors. Biological heterogeneity, drug resistance, and chemotherapy side effects are the biggest obstacles to the effective treatment of RCC. The NF-κB transcription factor is...
Enregistré dans:
| Publié dans: | Oncol Res |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cognizant Communication Corporation
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7844753/ https://ncbi.nlm.nih.gov/pubmed/29212573 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504017X15120379906339 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|